Language switcher

This page has not been translated yet

Professor Dr Venkatraman Ramakrishnan

Nobel Prize for Chemistry 2009

  • Section Biochemistry and Biophysics
  • Location Cambridge, United Kingdom
  • Election year 2010

Research

Research Priorities: Ribosome, protein biosynthesis, proteins, translation, crystal structure, antibiotics
Venkatraman Ramakrishnan is an Indian-British-American structural biologist. In 2009, he received the Nobel Prize in Chemistry together with the US-american molecular biologist Thomas A. Steitz and the Israeli structural biologist Ada Yonath. The three researchers have decoded the ribosome, the protein factory of the cell, described its three-dimensional structure and elucidated the mechanism of protein production.
Ribosomes are molecule complexes consisting of hundreds of thousands of atoms. They are divided into two subunits. In protein biosynthesis, ribosomes translate genetic information into proteins. This process is known as translation. Proteins assume many tasks in organisms and are responsible for the entire metabolic process. Venkatraman Ramakrishnan’s research has contributed to the understanding of translation. Using x-ray structural analysis, he investigated the ribosomes of the bacteria Thermus thermophilus and – in the same year as the Israeli structural biologist Ada Yonath – decoded the smaller subunit’s structure. At almost the exact same time, American biochemist Thomas Steitz published the first crystal structure of the larger subunit. The knowledge gained by the three researchers has contributed to the understanding of protein creation – one of the basic life processes.
In his further research work, Ramakrishnan investigated the ribosome subunit’s binding to various antibiotics. Many of the antibiotic substances latch on to the bacteria's ribosomes and inhibit these. However, the increase in antibiotic resistance is a challenge for medicine. Only a few substances are still available as reserve antibiotics. Ramakrishnan and his colleagues hope that their research will help to develop a new generation of antibiotics which can more specifically inhibit the protein synthesis of bacteria ribosomes and thus cause less resistance.
Over the last years Venkatraman Ramakrishnan’s work group has focused on exploring which factors start the translation process in a protein’s genetic information. The researcher was able to identify at least twelve factors that bind to the small subunit of the ribosome and thus give the starting signal for the ribosome to read the mRNA step by step. The better researchers understand the regular translation pathway, the earlier they will be able to detect the fatal deregulation that can result in tumour diseases or neuronal degeneration. Alongside x-ray structural analysis, high-resolution electron microscopy provides biochemistry with deeper insights into the translation process.

  • 2015-2020 President, Royal Society, UK
  • 2006-2008 Fellow, Trinity College, Cambridge, UK
  • since 1999 Team Leader, MRC Laboratory for Molecular Biology Cambridge, Medical Research Council (MRC), Cambridge, UK
  • 1995-1999 Professor of Biochemistry, University of Utah, Salt Lake City, USA
  • 1983-1995 Research Associate, Biology Department, Brookhaven National Laboratory, Long Island, USA
  • 1982-1983 Research Associate, Oak Ridge National Laboratory, Oak Ridge, USA
  • 1978-1982 Postdoctoral Fellow in Chemistry, Yale University, New Haven, USA
  • 1976-1978 Degree in Biology, University of California, San Diego, USA
  • 1976 PhD in Physics, Ohio University, Athens, USA
  • 1971 BSc in Physics, Maharaja Sayajirao University of Baroda, Baroda (since 1974: Vadodara), India

  • since 2019 Science Partner, Ahren Innovation Capital, London, UK
  • 2008-2011 Member, Scientific Advisory Board, Research Institute for Molecular Pathology (IMP), Vienna, Austria
  • 2008-2015 Editorial Advisory Board, Proceedings of the National Academy of Sciences of the United States of America (PNAS), USA
  • 2004-2011 Member, Scientific Advisory Board, Rib-X Pharmaceuticals Inc., New Haven, USA
  • 2013-2015 Member, Scientific Advisory Board, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
  • 2002-2006 Member, Scientific Advisory Board, EMBL, Heidelberg, Germany
  • 2001-2015 Editorial Advisory Board, Cell

  • 2020 Member, American Philosophical Society, USA
  • 2014 Jimenez Díaz Prize & Lecture, Fundación Conchita Rábago, Madrid, Spain
  • 2012 Sir Hans Krebs Medal and Lecture, Annual Meeting, Federation of European Biochemical Societies (FEBS), Seville, Spain
  • 2012 Knights Bachelor, New Year Honours, UK
  • 2010 Padma Vibhushan, Civilian Award, President of India, India
  • since 2010 Member, German National Academy of Sciences Leopoldina, Germany
  • 2009 Rolf Sammet Visiting Professor, Goethe-University, Frankfurt, Germany
  • 2009 Nobel Prize in Chemistry (together with Thomas A. Steitz and Ada Yonath), Royal Swedish Academy of Sciences, Sweden
  • 2008 Foreign Member, Indian National Science Academy, India
  • 2008 Heatley Medal, British Biochemical Society, UK
  • 2007 Datta Lecture and Medal, FEBS, Seville, Spain
  • 2007 Louis-Jeantet Prize for Medicine, Louis-Jeantet Foundation, Geneva, Switzerland
  • since 2004 Member, National Academy of Sciences, USA
  • since 2003 Member, Royal Society, UK
  • since 2002 Member, European Molecular Biology Organization (EMBO)
  • 1991-1992 Guggenheim Fellowship, John Simon Guggenheim Memorial Foundation, New York City, USA

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸